Equities
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)79.71
  • Today's Change-0.540 / -0.67%
  • Shares traded2.11m
  • 1 Year change-26.25%
  • Beta0.8632
Data delayed at least 15 minutes, as of Aug 15 2022 08:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.

  • Revenue in CNY (TTM)1.59bn
  • Net income in CNY589.45m
  • Incorporated1998
  • Employees2.14k
  • Location
    Joinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
  • Phone+86 1 067869582
  • Fax+86 1 067869966
  • Websitehttp://www.joinn-lab.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
603127:SHH since
announced
Transaction
value
Guangxi Weimei Bio-Tech Co LtdDeal completed29 Apr 202229 Apr 2022Deal completed-13.00%147.13m
Yunnan Yinmore Bio-Tech Co LtdDeal completed29 Apr 202229 Apr 2022Deal completed-13.00%125.23m
Data delayed at least 15 minutes, as of Aug 15 2022 08:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
China Southern Pwr Grd Technology Co Ltd1.48bn158.49m22.40bn330.00142.879.30--15.260.28070.28072.634.31------4,496,127.00--------29.18--10.68--4.34--0.0601--24.28--64.25------
Milkyway Chemical Sply Chn Srvce Co Ltd11.45bn552.24m23.07bn3.36k42.206.68--2.033.353.3569.6621.181.65100.726.103,407,257.008.118.5514.1813.709.9014.044.916.471.3516.460.47713.79152.2655.8949.6750.4447.27--
Wuchan Zhongda Group Co Ltd575.78bn3.96bn24.10bn21.01k5.930.7409--0.04150.77630.7763112.756.213.7812.8243.7327,402,540.003.934.2315.3312.442.602.621.041.060.671--0.568438.6339.2522.1146.9115.1817.88-13.65
CNOOC Energy Technology & Services Ltd40.39bn1.37bn25.21bn14.93k18.491.22--0.62170.13360.13364.092.031.2537.614.282,706,025.004.554.486.847.4412.7712.883.634.211.52--0.059622.1716.6614.86-15.6515.5913.50--
Joinn Laboratories China Co Ltd1.59bn589.45m38.86bn2.14k66.295.58--23.821.141.142.9513.610.19131.189.79741,431.307.0912.178.2916.5548.2950.8437.0731.493.52--0.01227.8240.9744.3776.9660.9035.25--
Data as of Aug 15 2022. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

15.32%Per cent of shares held by top holders
HolderShares% Held
Zhong Ou Asset Management Co., Ltdas of 31 Dec 202117.88m5.58%
China Universal Asset Management Co., Ltd.as of 31 Dec 20217.55m2.36%
GF Fund Management Co., Ltd.as of 31 Dec 20214.32m1.35%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 20214.24m1.32%
Harvest Fund Management Co., Ltd.as of 31 Dec 20213.83m1.19%
China Southern Asset Management Co., Ltd.as of 31 Dec 20213.77m1.18%
China Merchants Fund Management Co., Ltd.as of 31 Dec 20213.36m1.05%
Hwabao WP Fund Management Co., Ltd.as of 31 Dec 20211.87m0.59%
Galaxy Asset Management Co., Ltd.as of 31 Dec 20211.15m0.36%
Cinda Fund Management Co. Ltd.as of 31 Dec 20211.11m0.35%
More ▼
Data from 31 Dec 2021 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.